FDA Okays CAR T-Cell Therapy for Marginal Zone Lymphoma

Liso-cel now has five approved indications, the most of any CD19-targeted CAR T-cell therapy.
Medscape Medical News

Source link : https://www.medscape.com/viewarticle/fda-okays-car-t-cell-therapy-marginal-zone-lymphoma-2025a1000y5g?src=rss

Author :

Publish date : 2025-12-05 16:22:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

FDA Okays CAR T-Cell Therapy for Marginal Zone Lymphoma

Tattooing may trigger localised damage to the immune system

CDC Panel Drops Recommendation That All Babies Get Hep B Shot at Birth

Related Posts

CDC Panel Drops Recommendation That All Babies Get Hep B Shot at Birth

Tattooing may trigger localised damage to the immune system

Leading Drug Fails to Slow Alzheimer’s Progression

Enrollment in Medicare’s Diabetes Prevention Program Has Been ‘Pathetic’

New CDC Leadership; The Business of MAHA; Eugenics Enters the Chat

Makary Claims Biden Team Hid COVID Vax Risks; Rabies via Transplant; 200K Kid Deaths

CDC Panel Drops Recommendation That All Babies Get Hep B Shot at Birth

FDA Okays CAR T-Cell Therapy for Marginal Zone Lymphoma

Tattooing may trigger localised damage to the immune system

Leading Drug Fails to Slow Alzheimer’s Progression

Enrollment in Medicare’s Diabetes Prevention Program Has Been ‘Pathetic’

New CDC Leadership; The Business of MAHA; Eugenics Enters the Chat

Makary Claims Biden Team Hid COVID Vax Risks; Rabies via Transplant; 200K Kid Deaths

Real-World Data Support for Lecanemab in Early AD

Categories

Archives